Solera Study: Curated Digital Health Delivers Validated Savings

PHOENIX, AZ – May 04, 2026 – A new, independently validated study is sending a clear message to the U.S. healthcare industry: a structured, curated approach to digital health can deliver significant, measurable financial returns and improve patient outcomes. Solera Health, a Phoenix-based digital health company, today released findings from a real-world claims analysis demonstrating that its network model reduced total healthcare costs by $1,241 per member over just six months.

The study, conducted in partnership with an unnamed large U.S. health plan, found that for every dollar invested in Solera's platform, the plan saw a return of $2.42. These results provide concrete evidence in a sector often saturated with promising but unproven technologies, suggesting a potential shift in how health plans approach the multi-billion dollar problem of chronic disease management.

A New Benchmark for Digital Health ROI

For years, health plans and employers have grappled with the "point solution" problem—contracting with dozens of separate vendors for conditions like diabetes, hypertension, and behavioral health. This fragmentation has been shown to increase administrative burden and create a confusing experience for members, with the return on investment often remaining elusive. A recent industry report highlighted that over 40% of large employers juggle eight or more digital health vendors, incurring median annual management costs of over half a million dollars on top of program fees.

Solera's study directly confronts this challenge. The analysis of 16,499 enrolled members against a matched control group of nearly 35,000 others revealed systemic cost reductions. At scale, the company projects these savings could translate to a 2% to 4% reduction in a health plan's total claims costs—a figure that represents millions of dollars for large payers.

“The question was never whether digital health could work. It was whether anyone was willing to build it in a way that could be proven,” said Dr. Mohammed Saeed, chief medical officer at Solera Health, in the company's announcement. “This study answers that – and raises the bar for everyone in the space.”

The savings were not confined to a single area. The analysis of medical and pharmacy claims showed lower outpatient spending, reduced pharmacy costs indicative of better medication adherence, and, most critically, a significant reduction in high-acuity events. The study reported 55 fewer emergency room visits and hospitalizations per 1,000 members, a key indicator that proactive, well-managed care is preventing costly crises.

The Network Effect: Moving Beyond Fragmented Care

At the heart of these results is Solera's model, which eschews the traditional vendor-stacking approach. Instead, the company operates a curated network of over 25 digital health partners, all accessible through its single-integration HALO platform. This "network effect" acts as a central nervous system for a health plan's digital offerings.

Rather than leaving members to navigate a complex ecosystem of apps and programs, the platform intelligently guides them to the most appropriate solution for their specific needs, whether it's for weight management, musculoskeletal care, or diabetes. For health plans, this simplifies vendor management, and for members, it creates a streamlined, personalized path to care. Critically, Solera’s payment model is tied to performance, meaning the health plan pays only when members engage and achieve specific, clinically meaningful outcomes.

“Results like these don’t happen by accident,” said John Santelli, CEO at Solera Health. “They happen when you stop adding vendors and start building a system. This is what it looks like when digital health is an integrated part of care delivery – and that needs to become the baseline expectation.”

This integrated strategy appears to be the key differentiator, providing the "connective tissue" that many health systems lack. By creating a unified framework, the model aims to drive consistent engagement and allows for the tracking of outcomes across an entire population, something that is nearly impossible when managing a portfolio of disconnected point solutions.

The Critical Role of Independent Validation

In an industry where marketing claims can often outpace clinical evidence, the methodology of the Solera study is as significant as its results. The use of a matched-control claims analysis, a common method in health economics, provides a robust comparison point. Furthermore, the decision to have the methodology and statistical approach independently validated by a third party, Accorded, LLC, lends significant credibility.

This step towards accountability is a direct response to growing skepticism from payers who have been burned by digital health solutions that fail to deliver on their promises. However, experts note that while real-world evidence (RWE) studies like this one are invaluable for understanding effectiveness in a broader population, they are not without limitations. Unlike highly controlled randomized controlled trials (RCTs), RWE studies can be susceptible to selection bias and confounding variables that are difficult to isolate.

The anonymity of the "large U.S. health plan" that partnered in the study also raises questions about the generalizability of the findings. The specific demographics, geographic location, and existing health profile of the plan's members could influence the results, making it difficult to know if the same level of success would be replicated in a different population, such as Medicare or Medicaid members versus a commercial group. Despite these considerations, the study's design and third-party validation represent a significant step forward in establishing trust and transparency in the digital health market.

Sustaining Momentum: The Question of Long-Term Impact

The study's six-month timeframe provides a compelling snapshot of initial impact, but the ultimate test for any chronic condition management program is long-term sustainability. Chronic diseases require lifelong management, and a common challenge for digital health interventions is maintaining member engagement after the initial novelty wears off. Experts in chronic disease management emphasize that for interventions to be effective over years, they must integrate seamlessly into a patient's life and provide continuous, evolving support.

Solera appears to be proactively addressing this challenge by investing in machine learning and predictive analytics. The company is developing tools, such as its "Precision Insights" suite, designed to identify rising-risk patients before their conditions escalate. By analyzing claims data and health history, these tools aim to provide personalized provider recommendations and interventions, optimizing patient-provider matching to improve outcomes and further reduce avoidable costs.

This forward-looking strategy suggests an ambition beyond short-term gains, focusing instead on creating a continuously learning health system that can adapt to a member's needs over time. By proving its value with validated, real-world data and simultaneously building technology to ensure long-term impact, Solera is not just presenting impressive results; it is attempting to define the new standard for how digital health solutions demonstrate their worth and integrate into the fabric of healthcare delivery.